Mraz Amerine & Associates’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-8,549
Closed -$603K 164
2016
Q3
$603K Hold
8,549
0.21% 72
2016
Q2
$648K Hold
8,549
0.23% 67
2016
Q1
$587K Sell
8,549
-200
-2% -$14.4K 0.22% 68
2015
Q4
$765K Sell
8,749
-300
-3% -$25.7K 0.29% 57
2015
Q3
$733K Hold
9,049
0.29% 52
2015
Q2
$805K Sell
9,049
-195
-2% -$17K 0.3% 57
2015
Q1
$802K Sell
9,244
-50
-0.5% -$4.19K 0.3% 56
2014
Q4
$787K Hold
9,294
0.3% 55
2014
Q3
$656K Buy
+9,294
New +$662K 0.25% 67

Other funds holding ESRX

Mraz Amerine & Associates's ESRX Position: Q4 2016 in Review

Mraz Amerine & Associates sold out of Express Scripts Holding Company (ESRX) in Q4 2016, closing a stake of 8,549 shares — an estimated $603K sold.

Mraz Amerine & Associates first reported a position in ESRX in Q3 2014 and held it in 9 quarters. The position peaked at $805K in Q2 2015. 1,151 funds tracked by Wall St. Rank hold ESRX as of Q4 2016.

  • Mraz Amerine & Associates reported no remaining Express Scripts Holding Company position as of Q4 2016 after selling out during the quarter.
  • Mraz Amerine & Associates sold 8,549 Express Scripts Holding Company shares in Q4 2016, an estimated $603K.
  • Mraz Amerine & Associates first reported a position in Express Scripts Holding Company in Q3 2014 and held it in 9 quarters.
  • Mraz Amerine & Associates's Express Scripts Holding Company position peaked at $805K in Q2 2015.
  • 1,151 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2016.

Based on Mraz Amerine & Associates's 13F filing for Q4 2016, filed 31 Jan 2017.